(Q38489488)

English

Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer.

scientific article published on March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Byoung Chul Cho

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Young Joo Lee

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Se Kyu Kim

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jin Wook Moon

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

In Kyu Park

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Joo-Hang Kim

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

0 references

publication date

1 March 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

116

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1336-1343

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20066717%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

21 January 2018

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Pronostic factors of synchronous brain metastases from lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

The elderly with synchronous non-small cell lung cancer and solitary brain metastasis: does palliative thoracic radiotherapy have a useful role?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Central Nervous System Metastases in HER-2 Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Incidence, Survival, and Risk Factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent EGFR mutations in brain metastases of lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of stat3 in human melanoma promotes brain metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brain.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival after brain metastases from breast cancer in the trastuzumab era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Utility of Continuing Trastuzumab Beyond Brain Progression in HER-2 Positive Metastatic Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Cranial irradiation in cancer of the lung of all cell types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24877

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38489488&oldid=1508606907"